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Background: Traditional preparations of the root of Biebersteinia multifida DC (Geraniaceae), a native medicinal
plant of Irano-Turanian floristic region, have been used for the treatment of phobias as anxiolytic herbal
preparation.
Methods: We utilized the phobic behavior of mice in an elevated plus-maze as a model to evaluate the anxiolytic
effect of the plant extract and bio-guided fractionation was applied to isolate the active compounds. Total root
extract, alkaline and ether fraction were administered to mice at different doses 30 and 90 min prior to the maze
test. Saline and diazepam were administered as negative and positive controls, respectively. The time spent in open
and closed arms, an index of anxiety behavior and entry time, was measured as an index of animal activity.
Results: The total root extract exhibited anxiolytic effect which was comparable to diazepam but with longer
duration. This sustained effect of the crude extract was sustained for 90 min and was even more after injection of
45 mg/kg while the effect of diazepam had been reduced by 90 min. The anxiolytic effect factor was only present
in the alkaline fraction and displayed its effect at lower doses than diazepam while pure vasicinone as the
previously known alkaloid did not shown anxiolytic effect. The effect of the alkaline fraction was in a dose
dependent manner starting at 0.2 mg/kg with a maximum at 1.0 mg/kg. Bio-guided fractionation using a variety of
chromatographic methods led to isolation and purification of three coumarin derivatives from the bioactive
fraction, including umbelliferone, scopoletin, and ferulic acid.
Conclusion: For the first time, bio-guided fractionation of the root extract of B. multifida indicates significant
sustained anxiolytic effects which led to isolation of three coumarin derivatives with well-known potent MAO
inhibitory and anti-anxiety effects. These data contribute to evidence-based traditional use of B. multifida root for
anxiety disorders.
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Biebersteinia multifida DC (Geraniaceae), a native plant of
Irano-Turanian floristic regions [1], is known traditionally
as Chelleh-Dagh or Adamak in Iran. All four species of
Biebersteinia distributed geographically from central Asia
to Greek in temperate mountain zones. Among these
pharmacologically active species, only B. multifida and B.
orphanidis have tuberous roots. In folk medicine, the* Correspondence: mhghahremani@tums.ac.ir
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distribution, and reproduction in any mediumtuberous roots of B. multifida have been used topically for
the relief of inflammation and pain of musculoskeletal dis-
orders [2,3] and orally in the treatment of nocturia in chil-
dren and of phobia and anxiety in humans and domestic
animals [4] with no systematic approach to characterize
the observed ethnopharmacological effects. Thus far, isola-
tion of an alkaloid, vasicinone, and number of polysaccha-
rides and peptide substances has been reported [5].
Flavonoids including 7-glucosides of apigenin, luteolin,
and tricetin, as well as the 7-rutinoside of apigenin and
luteolin have been isolated from its leaves which in part
are responsible for antioxidant and antihemolytic activities
[6-8]. Recently, essential oil composition of B. multifidad Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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(E)-nerolidol, phytol, 6,10,14-trimethyl-2- pentadecanone
and hexadecanoic acid [9].
Ethnopharmacological studies have revealed that the
root extract of this plant has anti-inflammatory and
analgesic activities that confirm the traditional use of
B. multifida for the treatment of joint disturbances as
well as in restoring bone fractures [10]. However, no
report has yet been made on the anti-anxiety effects of
the plant.
The elevated plus-maze has been developed as an
ethological model of provoked anxiety and its use for
the study of animal anxiety-like behavior has been
pharmacologically validated and widely used for rats and
mice [11-13]. In the present study, we have utilized the
phobia behavior of mice in the elevated plus-maze as a
model to evaluate the anxiolytic effect of the plant. For
this purpose, the anxiolytic effects of the total root ex-
tract of B. multifida and its fractions were evaluated in




All chemicals were obtained from Merck (Darmstadt,
Germany). Solvents used in chromatography methods
were HPLC-grade. Diazepam (purity: not less than
98.0%) was obtained from Chemidarou Pharmaceutical
Company (Tehran, Iran). Vasicinone (purity ≥97%) was a
generous gift from Dr. Vahid Ziaee in Department of
Medicinal Chemistry, Tehran University of Medical
Sciences.
Plant materials
The plant materials were collected from the region of
Ruine, located in North Khorasan Province of Iran fol-
lowing the national rule on biodiversity by local agent of
Iran Department of Environment. A voucher specimen
has been deposited at the Herbarium of the Faculty of
Pharmacy, Tehran University of Medical Sciences (Vou-
cher No. 6691 TEH) by Prof. GR Amin. The root of the
plant was used in this study.
Chromatographic apparatus
A high performance liquid chromatography (HPLC)
instrument equipped with K-1001 pump (Knauer,
Germany), a D-14163 manual injector valve (Rheodyne),
and a K-2600 UV detector for peak detection was used in
the analytical studies. Another HPLC instrument (Knauer,
Germany) including preparative K-1800 pumps (Double),
two switching valves and a K-2501 UV detector were used
for preparative purification. Solvents were filtered through
a Millipore system and separation was performed on
Knauer Eurosphere 100 C18 columns (150 mm× 4.0 mm,I.D. 5 μm) and (120 mm× 16 mm, I.D. 5 μm) for analytical
and preparative HPLC, respectively.
Spectroscopy instruments
The 1H-NMR and 13C-NMR spectra of the isolated
compounds were measured in DMSO-d6 or CDCl3 at
500 and 125 MHz, respectively, using a Bruker AC 500
spectrophotometer (Germany). Mass spectra were pre-
pared on Finnigan-Mat TSQ-70 spectrometer (CA,
USA). Fourier-transform infrared (FTIR) spectra were
obtained with a Nicolet Magna-FTIR 550 spectrometer
(WI, USA).
Extraction procedures
The roots were collected from the field, cleaned, dried
for two weeks in the shade, then powdered and stored in
airtight containers. The total extract was prepared from
the powdered root refluxed with methanol for 72 hours
using a Soxhlet apparatus, followed by filtration. The
filtrate was concentrated using low-pressure distillation
at 45°C and evaporated to dryness. We obtained 690±1 g
of total extract solids from 4900 g powdered root
(14.08%). To prepare the fractions, an aliquot of 300 g of
the extract solids were re-suspended in 1400 mL of
water/acetic acid (95:5) solution and further extracted
with light petroleum ether (4 × 1000 mL) to separate the
lipophilic compounds (ether fraction, 4.3% of total ex-
tract). The remaining aqueous part was treated with am-
monia 25% and sequentially partitioned in chloroform
and ethyl acetate (4 × 1000 mL for each of them). The
solvent was removed under reduced pressure and the
total alkaline residue (1.6%) was used for the experi-
ments (alkaline fraction). All extracts were analyzed by
thin layer chromatography (TLC). Plant total extract was
prepared in 1% carboxymethylcellulose (CMC) in saline
prior to animal testing. The alkaline and ether fractions
were dissolved in saline containing 2% DMSO.
Pharmacological studies
Male Swiss white mice, 20–25 g, were obtained from the
Animal Care Facility (Faculty of Pharmacy, Tehran,
Iran). The animals were housed six per cage in a
temperature-controlled (22 ± 1°C) colony room. They
were maintained in a 12h light/dark schedule with ad
libitum food and water except during experimental pro-
cedures. All trials were carried out in the light phase.
Subjects were experimentally naïve and each mouse was
used only once. Animals were allowed 7 days to
acclimatize to the laboratory environment including
handling before testing began. All procedures were car-
ried out in accordance with institutional guidelines for
animal care and use. The protocol (No. 357) had been
approved by the Committee of Ethics of the Faculty of
Sciences of Tehran University.
Figure 1 Evaluation of the effects of a crude extract from
Biebersteinia multifida roots on mouse behavior on an elevated
plus-maze. A) The percent time spent in each arm and B) The
anxiolytic ratio as ratio of percent time spent in open arms to the
close arms (Ratio = % time in open arms/% time in closed arms). The
animals were injected 30 min prior to the test with saline (vehicle),
diazepam (1 mg/kg) or different doses of crude extract. Data are
presented as mean ± SE for each group (n = 12 in each group). The
dotted line indicates the Ratio (open/close) of the vehicle (saline).
*p value < 0.05, **p value < 0.01.
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neally (i.p.) in a single dose. Control groups received
vehicle in saline (saline group) or diazepam 1 mg/kg, as
a known anti-anxiety drug. The elevated plus maze
consisted two open arms (6 × 30 × 2 cm) and two closed
arms (6 × 30 × 10 cm), having an open roof, elevated 40
cm with a central platform of 8 × 8 cm. The test was
performed 30 and 90 min after injection. Each mouse
was placed in the central platform facing toward a closed
arm and the cumulative time spent in open or closed
arms was recorded for 5 min. The percent time spent was
used as the measure of plus-maze performance. The ratio
of percent time spent in open to closed arm (Ratio =
% time spent in open arms/% time spent in closed arms)
was indexed as the anxiolytic effect of various groups.
Based on this calculation, when the animal had equal pref-
erence for open and closed arms at ratio = 1, this was an
indicator of loss of anxiety. A ratio < 1 indicated that the
animal avoided the open arm, indicating anxiety behavior.
The entry time into each arm and the total entry time for
each mouse were used as an index of activity for each ani-
mal. There were 4 mice in each group and the experiment
was repeated 3 times, independently (n = 12).
Isolation, purification, and structure elucidation
The alkaline fraction (2 g) was subjected to column
chromatography (100 g silica gel) for clean-up and initial
fractionation. Elution with 1200 mL of CHCl3/EtOAC
(80:20) gave a fraction that contained major compounds
of the chloroform extraction. This fraction was further
purified by HPLC to yield compounds 1 and 2 as de-
scribed below. Compound 3 eluted from the column
with an Rf value greater than 1 and 2. This compound was
further purified by preparative TLC by CHCl3/EtOAC
(65:35) as the mobile phase.
For further purification, the CHCl3/EtOAC (80:20)
fraction from column chromatography was subjected to
preparative HPLC. Initially, a small amount of the fraction
was injected into the analytical HPLC and the compos-
ition of the mobile phase was optimized by varying the
percent of acetonitrile in phosphate buffer for separation
of compounds 1 and 2. The best purification was obtained
using the following conditions: acetonitrile/0.1 M phos-
phate buffer/glacial acetic acid (6:94:1 v/v/v), pH 4.15; flow
rate: 1.2 mL/min; detector wavelength 300 nm. After opti-
mizations using analytical HPLC, scale-up was performed
for preparative separation. A flow rate of 14 mL/min was
applied for preparative separation; other conditions were
identical with the analytical method. The CHCl3/EtOAC
(80:20) fraction was subjected to preparative HPLC and
pure compounds 1 (32 mg) and 2 (12 mg) were sepa-
rated collected in the mobile phase. The purity of these
two compounds was re-checked by analytical HPLC and
structure elucidation of the purified compounds wascarried out by spectroscopic methods (MS, FTIR, 1H
and 13C-NMR).
Statistical analysis
The data obtained from independent pharmacological
experiments were pooled and reported as mean ± SEM.
The data were analyzed by one-way ANOVA followed
by Tukey post hoc multiple comparison. P < 0.05 was
considered significant.
Results
The anxiolytic effect of total extract in mice
In animals receiving the total extract of the roots and
tested 30 min after injection, the time spent in open arm
was prolonged compared to the animals that received sa-
line (Figure 1). The effect was first seen at a dose of 25 mg
extract/kg body weight and increased in a dose dependent
Table 1 The effect of total extract of Biebersteinia multifida on the behavior of mice on an elevated plus-maze
Total entry Percent entry into open arms
Treatment 30 min 90 min 30 min 90 min
Saline 14.5 ± 1.5a 14.5 ± 0.9 41.2 ± 3.8 39.2 ± 4.3
Diazepam (1 mg/kg) 24.2 ± 2.7 18.3 ± 2.2 57.2 ± 3.55 44.2 ± 2.4
Extract (25 mg/kg) 15.7 ± 1.3 16.1 ± 1.3 41.2 ± 2.4 46.4 ± 2.2
Extract (35 mg/kg) 12.4 ± 1.3 14.3 ± 0.8 43.1 ± 1.7 44.2 ± 3.5
Extract (45 mg/kg) 16.4 ± 1.0 12.8 ± 1.4 50.5 ± 2.2 52.1 ± 2.8
Extract (50 mg/kg) 15.5 ± 3.6 10.0 ± 2.2 48.8 ± 1.9 44.0 ± 12.3
Extract (75 mg/kg) 8.2 ± 1.2 NDb 53.0 ± 6.2 ND
aThe data are presented as mean ± SE (n = 12).
bND not determined.
The table indicates the total entry and percent entry into open arms as an indicator of the activity of the animal. The entry to each arm was measured at 30 and
90 min after administration of the total extract.
Figure 2 The time dependency of the anxiolytic effect of total
extract. Effects were analyzed by performing the test at 30 min and
90 min after injection. The animals were injected 30 min prior to the
plus maze test with saline (vehicle), diazepam (1 mg/kg) and
different doses of crude extract of the plant. The ratio of percent
time spent in open arms to close arms was calculated and plotted
as mean ± SE for each group (n = 12 in each group).
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mals spent equal time in the open and closed arms. The
effect of 45 mg/kg of the total extract was comparable to
that of diazepam at 1 mg/kg, where the mice showed a
slightly more, but not significant, preference for the open
arm (Figure 1A). At lower dose (10 mg/kg), the animals
behaved similar to those given the saline treatment. At
higher doses (50 and 75 mg/kg), the animals continued to
show equal preference for the open and closed arms. The
extract had very little effect on the activity of the animals
at the doses used. As indicated in Table 1, the total entries
into the closed and open arms are equal in all groups. In
animals receiving 50 and 75 mg/kg of the extract, the
entries were lower and they were mostly in sleep (Table 1).
To compare the anxiolytic effect in various groups, we cal-
culated the ratio of percent time spent in open arm to
closed arm (see Materials and Methods) for each group
(Figure 1B). The ratio = 1 indicates an equal preference for
the open and the closed arms, representing loss of anxiety;
and the ratio lower than 1 implies less preference for the
open arm and an increase in anxiety behavior. This ratio
in animals receiving 25 mg/kg of the total extract was
higher (0.64±0.09) than in the saline group (0.44±0.07),
indicating a trend toward preference for the open area
although the difference was not statistically significant
(Figure 1B). The anxiolytic ratio increased with increases
in the dose of total extract and reached 1.07±0.15 in the
mice that received 45 mg/kg of the total extract (p < 0.01
compared to saline), suggesting a lack of anxiety. This ratio
was comparable to that obtained with diazepam (1.19±0.22,
p < 0.01 compared to saline, Figure 1B). In order to evaluate
the duration of anxiolytic effect, we also tested the effect
of total extract 90 min after injection. As seen in Figure 2,
the anxiolytic effect of the plant extract was sustained for
90 min. This anxiolytic ratio was even higher at 90 min
after injection of 45 mg/kg of the total extract (p < 0.05
compared to 30 min, Figure 2). On the other hand, the
effect of diazepam had been reduced considerably by90 min. This observation suggests a longer duration of
action for the extract compared to that of diazepam
(Figure 2).
The anxiolytic effect of alkaline and ether fractions
To further isolate the active compounds in B. multifida,
the total root extract was fractionated as mentioned in
Materials and Methods. Alkaloids of this plant may be
responsible for its pharmacological activities [10]; thus
we examined the anxiolytic activity of the alkaline and
ether (lipophilic compounds) fractions of the root
extract. Figure 3 shows the effects of various doses of
the alkaline fraction on animal performance on elevated
plus-maze 30 min after injection. An increase in ten-
dency toward presence in the open arm was seen as the
dose of the alkaline fraction was increased (Figure 3).
The anxiolytic ratio calculated for these experiments
Figure 3 The effect of an alkaline fraction of a Biebersteinia
multifida root extract on the behavior of mice on an elevated
plus-maze by the percent time spent in each arm. The animals
were injected 30 min prior to the test with saline (vehicle), diazepam
(1 mg/kg) or different doses of alkaline fraction. Data are presented
as mean ± SE for each group (n = 12 in each group).
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a dose of 0.2 mg/kg and the maximum effect was
obtained at 1.0 mg/kg of the alkaline fraction. The activity
of the animals indicated as total entries into the arms
show no significant differences among the various groups
(Table 2). We also studied the effect of the alkaline frac-
tion 90 min after injection. As Figure 4 shows, unlike the
diazepam treated group, the anxiolytic effect of alkaline
fraction continued to be seen 90 min after injection,
suggesting a sustained effect for this fraction.
We also tested the ether fraction of plant extract,
which contained lipophilic compounds. At doses of 3
and 6 mg/kg of the ether fraction, the animals showed
no significant anxiolytic effects compared to saline
treated group (Figure 5A). The 3 and 6 mg of ether
fraction were equivalent to 69.7 and 139.5 mg of total
extract, respectively. The effect of the ether fraction wasTable 2 The effect of alkaline fraction of Biebersteinia multifid
Total entry
Treatment 30 min
Saline 14.2 ± 1.7a
Diazepam (1 mg/kg) 32.2 ± 4.1
Alkaline fraction (0.1 mg/kg) 19.2 ± 1.2
Alkaline fraction (0.2 mg/kg) 14.8 ± 0.7
Alkaline fraction (0.5 mg/kg) 13.8 ± 1.64
Alkaline fraction (0.75 mg/kg) 16.5 ± 1.5
Alkaline fraction (1.0 mg/kg) 23.0 ± 1.7
Alkaline fraction (1.5 mg/kg) 18.2 ± 2.7
aThe data are presented as Mean ± SE (n = 12).
bND not determined.
The table indicates the total entry and percent entry into open arms as an indicato
90 min after administration of the alkaline fraction.similar to saline and did not show any anxiolytic effect
at either 30 or 90 min after injection (Figure 5B).
Collectively, the alkaline fraction produced an anxiolytic
effect in a dose dependent manner starting at 0.2 mg/kg
and reaching a maximum effect at 1.0 mg/kg. This effect
was comparable to that seen for diazepam (1.0 mg/kg).
Doses of 0.2 and 1.0 mg/kg of alkaloid fraction were
equivalent to 12.5 and 62.5 mg/kg of the total root
extract.
Isolation, purification, and structure elucidation of
chemicals present in the alkaline fraction
The alkaline fraction that showed the anxiolytic effect
was subjected to different chromatography methods, as
mentioned in Materials and Methods, which led to
isolation and purification of three compounds.
Structure elucidation of compounds 1, 2, and 3 was
carried out by spectroscopic methods (MS, FTIR, 1H and
13C-NMR) and by comparison of acquired data with those
reported in the literature [14-17]. Compounds 1, 2, and 3
were identified as umbelliferone, scopoletin, and ferulic
acid, respectively (Figure 6, Additional file 1: Table S1 and
Additional file 2: Figure S1, Additional file 3: Figure S2,
Additional file 4: Figure S3, Additional file 5: Figure S4,
Additional file 6: Figure S5, Additional file 7: Figure S6) as
the major components of alkaloid fraction.
Discussion
The anti-inflammatory and analgesic activities of B.
multifida have been reported before [10]. We have
employed a bio-guided fractionation to study the anxio-
lytic effect of the extracts. This approach has been suc-
cessfully applied as a valuable strategy for the finding of
new lead compounds in phytochemical studies [18].
The use of the elevated plus-maze to study animal
anxiety-like behavior has been comprehensively studied
and pharmacologically validated for rats [11] and micea on the behavior of mice on an elevated plus-maze
Percent entry to open arms
90 min 30 min 90 min
8.8 ± 1.5 41.5 ± 3.3 39.9 ± 3.6
25.8 ± 6.2 60.5 ± 2.4 54.0 ± 6.4
15.4 ± 1.7 42.3 ± 4.1 41.7 ± 6.9
13.8 ± 1.4 48.8 ± 2.3 36.2 ± 2.5
9.5 ± 1.3 41.0 ± 4.4 37.7 ± 4.9
12.1 ± 1.1 51.2 ± 3.9 51.6 ± 3.6
13.0 ± 4.3 48.4 ± 2.0 59.9 ± 3.1
NDb 51.5 ± 2.7 ND
r of the activity of the animal. The entry to each arm was measured at 30 and
Figure 5 The effect of an ether fraction of a Biebersteinia
multifida root extract on the behavior of mice on an elevated
plus-maze. The animals were injected with ether fraction and the
percent time spent in each arms of the plus maze test was plotted
for each group. The ratio of time spent in open arms to close arms
was calculated as an indicator of anxiety and fear of open and
elevated area, and plotted for each group (Ratio = % time in open
arms/% time in closed arms). The graph presents the results of three
independent experiments (n =8 in each group).
Figure 4 The time dependency of the anxiolytic effect of an
alkaline fraction from Biebersteinia multifida roots on mice. The
elevated plus-maze test was performed 30 min and 90 min after
injection. The animals were injected 30 min prior to the test with
saline (vehicle), diazepam (1 mg/kg) or different doses of alkaline
fraction. The ratio of percent time spent in open arms to close arms
was calculated and plotted as mean ± SE for each group (n = 12 in
each group).
Figure 6 Chemical structures of compounds isolated from a
Biebersteinia multifida root extract, including umbelliferone (1),
scopoletin (2) and ferulic acid (3).
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or open time ratio were used as an indicator of anxiety
behavior in mice and rats [11,13]. Since locomotion is
an important factor in the elevated plus-maze, the total
entry time has been used as an indicator of activity
[11,13]. In this study, the time spent in each arm, the
open and closed time ratio, was used to evaluate the
anxiety behavior, while the total entry time considered
as an index of animal activity.
A bio-guided phytochemical analysis of B. multifida
has not previously been reported. Although other
reports have thus far identified a number of flavonoids, a
few polysaccharides and one alkaloid (vasicinone) from
root extract, in which vasicinone considered as the
responsible molecule for observed pharmacological ac-
tivities [5-7,9], there were no direct relation between the
isolated compounds to traditional use of B. multifida.
Thus, to identify the active anxiolytic components, the
total extract is fractioned into alkaline and ether frac-
tions and subjected to anxiety alleviation studies. The
anxiolytic compounds act readily in alkaline fraction
form while the ether fraction showed little anxiolytic
effect. This bio-guided fractionation indicates that the
active compounds are present in the alkaline fraction.
Furthermore, the results suggest that the alkaloid extract
has a sustained anxiolytic effect compared to that ob-
served with diazepam. Diazepam is a known anxiolytic
used as control in various pharmacological studies. In
this study, our results indicate a strong anti anxiety
effect in animals receiving diazepam (Figures 1 and 2).
Interestingly, the anxiolytic effect of diazepam has
been reduced considerably by 90 min (Figure 2). Thus
compared to diazepam, the plant extract has a longer
duration of action.Before any further chromatographic studies, the effects
of pure vasicinone -as the suspected active compound in
the alkaloid fraction- on mouse performance is tested by
the same experimental procedure as described above.
The analysis of vasicinone, at doses as high as 10 mg/kg,
had no significant effect on open time ratio (data not
shown). Thus, the alkaline fraction is further characterized
for the major components present which lead to isolation
and structure elucidation of three compounds of coumarin
derivatives including umbelliferone, scopoletin, and ferulic
acid. However the presence of ferulic acid after alkaline
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scopoletin after extraction.
According to previous reports, coumarin derivatives, in-
cluding scopoletin and umbelliferone, are potent inhibitors
of monoamine oxidases (MAOs) [19,20]. Scopoletin shows
MAO inhibition activity in a dose-dependent fashion, with
IC50 values of 19.4 μg/mL [19]. In addition, daphnoretin a
bicoumarin of scopoletin and umbelliferone exhibits
significant anxiolytic activity in EPM model [21-23]. It has
been also suggested that coumarin derivatives interact
with the benzodiazepine binding site of the GABA-A
receptor [24]. This may explain the effects observed in the
present study and may confirm at least a partial role of
these coumarins anxiolytic effects of B. multifida.
In addition to the anxiolytic effect, scopoletin is also
a known potent anti-inflammatory agent [25,26], which
can explain, in part, the anti-inflammatory and anti-
nociceptive effects of B. multifida extracts. The ability
of low molecular weight substances to cross the
blood–brain barrier could explain the reported central
anti-nociceptive effect [10]. However, this needs further
specific pure substance studies in validated pharmaco-
logical models.
In conclusion, for the first time, bio-guided fraction-
ation of the root extract of B. multifida indicates signifi-
cant sustained anxiolytic effects which led to isolation
of three coumarin derivatives of those scopoletin and
umbelliferone with known MAO inhibitory and anti-
anxiety effects. These data contribute to evidence-based
traditional medicines using root of B. multifida for anxiety
disorders.Additional files
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